Individual holder
MYLARI BANAVARA L
US·2 granted patents·10 pending applications·5 citations·filing 2012–2019
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
12 records- 0186US8853259B2Metformin derivatives for treating diabetes and diabetes complicationsMYLARI BANAVARA L·Filed 2014·Granted Oct 7, 2014·5 cites·26 claims
- 0253US2012178813A1Lipid-lowering antidiabetic agentMYLARI BANAVARA L·Filed 2012·Application pending·0 cites
- 0351US8440723B2Metformin salts of salicylic acid and its congenersMYLARI BANAVARA L·Filed 2012·Granted May 14, 2013·0 cites·26 claims
- 0451US2014364500A1Ursolic acid salts for treating diabetes and obesityMYLARI BANAVARA L·Filed 2014·Application pending·0 cites
- 0549US2014323444A1Anti-inflammatory and antidiabetic agentsMYLARI BANAVARA L·Filed 2013·Application pending·0 cites
- 0649US2013252926A1Metformin salts of salicylic acid and it congenersMYLARI BANAVARA L·Filed 2013·Application pending·0 cites
- 0748US2014024708A1Ursolic acid salts for treating diabetes and obesityMYLARI BANAVARA L·Filed 2013·Application pending·0 cites
- 0846US2019263825A1Water soluble salts of aldose reductase inhibitors for treatment of diabetic complicationsMYLARI BANAVARA L·Filed 2019·Application pending·0 cites
- 0944US2014228319A1Water soluble salts of aldose reductase inhibitors for treatment of diabetic complicationsMYLARI BANAVARA L·Filed 2014·Application pending·0 cites
- 1042US2014011814A1Diamine and meglumine salt forms of fatty acidsMYLARI BANAVARA L·Filed 2013·Application pending·0 cites
- 1141US2017368079A1Anti-inflammatory and antidiabetic agentsMYLARI BANAVARA L·Filed 2016·Application pending·0 cites
- 1237US2017362237A1Water soluble salts of aldose reductase inhibitors for treatment of diabetic complicationsMYLARI BANAVARA L·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MYLARI BANAVARA L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →